SeaSpine Holdings Corporation is a medical technology firm specializing in the creation, development, and global marketing of advanced surgical solutions for treating spinal disorders. The company offers an extensive portfolio of orthobiologics and spinal implant systems, which are primarily utilized by neurosurgeons and orthopedic spine specialists to perform spinal fusion procedures in the cervical, thoracic, and lumbar regions. Their orthobiologic product line features various bone graft substitutes, including demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allografts, and synthetic bone void fillers.